Recruiting OBSERVATIONAL NCT04522687

Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer

Observation of the Impact of Radiotherapy With or Without Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets for Patients With Thoracic Cancer

Sponsor: Shanghai Cancer Hospital, China

Conditions Esophageal Squamous Cell Carcinoma NSCLC Thymic Epithelial Tumor

Updated 4 times since 2020 Last updated: Aug 19, 2020 Started: Jan 1, 2012 Primary completion: Dec 31, 2023 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Esophageal Squamous Cell Carcinoma and NSCLC, this trial is actively recruiting participants. The trial is conducted by Shanghai Cancer Hospital, China and has accumulated 4 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jan 2021 — Jul 2024 [monthly]

Recruiting
Sep 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Cancer Hospital, China

Data source: Shanghai Cancer Hospital, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China